Experimental studies indicate that the incidence of bone metastases and growth of osteolytic breast cancer cells is impaired in osteoclast-specific Tgfβr2 knockout mice, and this phenotype is rescued by FGF2. This evidence concerns the gene TGFBR2 and breast carcinoma.